New role of resistin in lipopolysaccharide-induced liver damage in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 325, Issue 3, 2008, Pages 801-808

  Beier, Juliane I ^a   Guo, Luping ^a   Von Montfort, Claudia ^a   Kaiser, J Phillip ^a   Joshi Barve, Swati ^a   Arteel, Gavin E ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BACTERIUM LIPOPOLYSACCHARIDE; FIBRINOGEN; GK PROTEIN; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; HIRUDIN; INSULIN; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOENOLPYRUVATE CARBOXYKINASE 1; PHOSPHOTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; RESISTIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEMOSTASIS; HEPATITIS; IN VIVO STUDY; LIVER INJURY; LIVER NECROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; FIBRIN; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; RESISTIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44249115065     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.136721     Document Type: Article

References (37)

1. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, et al. (2004) Regulation of fasted blood glucose by resistin. Science 303:1195-1198.
2. Bergheim I, Guo L, Davis MA, Lambert JC, Beier JI, Duveau I, Luyendyk JP, Roth RA, and Arteel GE (2006a) Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology 130:2099-2112.
3. Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, and Arteel GE (2006b) Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J Pharmacol Exp Ther 316:1053-1061.
4. Bertolani C, Sancho-Bru P, Failli P, Bataller R, Aleffi S, DeFranco R, Mazzinghi B, Romagnani P, Milani S, Gines P, et al. (2006) Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 169:2042-2053.
5. Bokarewa M, Nagaev I, Dahlberg L, Smith U, and Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789-5795.
6. Ganey PE, Luyendyk JP, Maddox JF, and Roth RA (2004) Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact 150:35-51.
7. Ganey PE and Roth RA (2001) Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents. Toxicology 169:195-208.
8. Guo L, Richardson KS, Tucker LM, Doll MA, Hein DW, and Arteel GE (2004) Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. Hepatology 40:583-589.
9. Haluzik M and Haluzikova D (2006) The role of resistin in obesity-induced insulin resistance. Curr Opin Investig Drugs 7:306-311.
10. Hamaguchi E, Takamura T, Shimizu A, and Nagai Y (2003) Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther 307:987-994.
11. Hewett JA and Roth RA (1995) The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from gram-negative bacteria. J Pharmacol Exp Ther 272:53-62.
12. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, et al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055.
13. Holdsworth SR, Thomson NM, Glasgow EF, and Atkins RC (1979) The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol 37:38-43.
14. Hotamisligil GS, Shargill NS, and Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91.
15. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, and Patsch JR (2003) Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309:286-290.
16. Koteish A, Yang S, Lin H, Huang X, and Diehl AM (2002) Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem 277:13037-13044.
17. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, and Lazar MA (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:161-168.
18. Loike JD, el Khoury J, Cao L, Richards CP, Rascoff H, Mandeville JT, Maxfield FR, and Silverstein SC (1995) Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucylphenylalanine. J Exp Med 181:1763-1772.
19. Lu SC, Shieh WY, Chen CY, Hsu SC, and Chen HL (2002) Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530:158-162.
20. Luyendyk JP, Maddox JF, Green CD, Ganey PE, and Roth RA (2004) Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide- ranitidine coexposure in rats. Hepatology 40:1342-1351.
21. Malhi H, Gores GJ, and Lemasters JJ (2006) Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43:S31-S44.
22. McTernan PG, Kusminski CM, and Kumar S (2006) Resistin. Curr Opin Lipidol 17:170-175.
23. Ort T, Arjona AA, MacDougall JR, Nelson PJ, Rothenberg Me, Wu F, Eisen A, and Halvorsen YD (2005) Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice. Endocrinology 146:2200-2209.
24. Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, Barzilai N, and Scherer PE (2002) Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 16:1920-1930.
25. Shaw A and Xu Q (2003) Biomechanical stress-induced signaling in smooth muscle cells: an update. Curr Vasc Pharmacol 1:41-58.
26. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, and Lazar MA (2001a) The hormone resistin links obesity to diabetes. Nature 409:307-312.
27. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, et al. (2001b) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98:502-506.
28. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, Tompkins RG, and Martyn JA (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282:E386-E394.
29. Takeuchi M, Nakashima Y, Miura Y, Nakagawa K, Uragoh K, Iwanaga S, Hori Y, and Sueishi K (1994) The localization of lipopolysaccharide in an endotoxemic rat liver and its relation to sinusoidal thrombogenesis: light and electron microscopic studies. Pathol Res Pract 190:1123-1133.
30. Tsochatzis E, Papatheodoridis GV, and Archimandritis AJ (2006) The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 101:2629-2640.
31. Vayalil PK, Iles KE, Choi J, Yi AK, Postlethwait EM, and Liu RM (2007) Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol 293:L1281-L1292.
32. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, et al. (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75-79.
33. Virkamäki A and Yki-Jarvinen H (1994) Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134:2072-2078.
34. Wickert L, Chatain N, Kruschinsky K, and Gressner AM (2007) Glucocorticoids activate TGF-beta induced PAI-1 and CTGF expression in rat hepatocytes. Comp Hepatol 6:5.
35. Xia Z, Dickens M, Raingeaud J, Davis RJ, and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
36. Yang SQ, Lin HZ, Lane MD, Clemens M, and Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94:2557-2562.
37. Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, et al. (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:150-156.